E
1952
vs
GILD
GILD
Over the past 12 months, Everest Medicines Ltd has underperformed GILD, delivering a return of -18% compared to the GILD's +32% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
GILD
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd
HKEX:1952
|
39.98
HKD
|
|||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
137.64
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
1952, GILD
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
E
|
Everest Medicines Ltd
Revenue
|
|||||||||||
|
|
Gilead Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
1952, GILD
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
E
|
Everest Medicines Ltd
HKEX:1952
|
|||||||||
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Everest Medicines Ltd | ||||
|
|
Gilead Sciences Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
1952, GILD
Performance Gap
1952, GILD
Performance By Year
1952, GILD
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
